ovarian-cancer

Documents about ovarian-cancer

• Hormonal and Reproductive Risk Factors for Epithelial Ovarian Cancer by Tumor Aggressiveness#384118CiNii
• BRCA testing in Asian ovarian cancer patients: Standard clinical practice or Mutation prediction model?#396734PubMed Central
• Management of skin metastases of ovarian cancer: a novel therapeutic approach#619820Deutsche Nationalbibliothek
• The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors#874757ClinicalTrials.gov
• Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25)#157612HAL (France)
• Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab#892677ClinicalTrials.gov
• TKM 080301 for Primary or Secondary Liver Cancer#914453ClinicalTrials.gov
• Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors#833985ClinicalTrials.gov
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation#908236ClinicalTrials.gov
• Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers#844793ClinicalTrials.gov
• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies#895092ClinicalTrials.gov
• Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece#879019ClinicalTrials.gov
• Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1#902755ClinicalTrials.gov
• Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors#829094ClinicalTrials.gov
• A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)#872711ClinicalTrials.gov
• Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors#899717ClinicalTrials.gov
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors#849329ClinicalTrials.gov
• An overview of the use of cutting-edge artificial intelligence (AI) modeling to produce synthetic medical data (SMD) in decentralized clinical machine learning (ML) for ovarian cancer(OC) and ovarian lymphoma(OL).#247735NCBI PubMed Central
• A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors#882426ClinicalTrials.gov
• Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors#879788ClinicalTrials.gov
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors#18576ClinicalTrials.gov
• Activation of Platelet-Activating Factor Receptor and Pleiotropic Effects on Tyrosine Phospho-EGFR/Src/FAK/Paxillin in Ovarian Cancer#169043Unpaywall
• Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures#867385ClinicalTrials.gov
• CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy.#154434NCBI PubMed Central
• KDM8/c-Myc axis-mediated glucose metabolism reprogramming promotes the progression of ovarian cancer.#220963NCBI PubMed Central
• Navigating Hope and Illness Cognition in Advanced Ovarian Cancer Patients: A CSM-Based Phenomenological Study.#280864NCBI PubMed Central
• Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors#374401HAL (France)
• DUSP5 contributes to platinum resistance in ovarian cancer: single-cell discovery and functional validation.#436994NCBI PubMed Central
• The PVR-TIGIT/CD96/CD226 axis: a novel immune checkpoint target in ovarian cancer.#653460NCBI PubMed Central
• Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer#676806HAL (France)
• Massage Therapy for Cancer-Related Fatigue#871774ClinicalTrials.gov
• ASO Visual Abstract: Impact of BRCA mutation status on tumor dissemination pattern, surgical outcome, and patient survival in primary and recurrent high-grade serous ovarian cancer (HGSOC). A multicenter, retrospective study of the ovarian cancer therapy—innovative models prolong survival (OCTIPS) consortium#308507ISTA Publications
• Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management#829025ClinicalTrials.gov
• A Study of DeTIL-0255 in Adults With Advanced Malignancies#859743ClinicalTrials.gov
• Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors#900069ClinicalTrials.gov
• Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression#837556ClinicalTrials.gov
• Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors#882565ClinicalTrials.gov
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer#910003ClinicalTrials.gov
• Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors#874390ClinicalTrials.gov
• Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study#890983ClinicalTrials.gov
• Investigator Initiated Phase 1 Study of TBI-1301#803168ClinicalTrials.gov
• The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial#811414ClinicalTrials.gov
• A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer#429755ClinicalTrials.gov
• Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors#840056ClinicalTrials.gov
• Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer#915353ClinicalTrials.gov
• EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs#14315HAL (France)
• IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC#136279ClinicalTrials.gov
• Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancer.#160030NCBI PubMed Central
• Effect of hysterectomy on the risk of ovarian cancer: A South Korean national cohort study.#160090NCBI PubMed Central
• HRD-Driven Reprogramming of Macrophage Function and Spatial Architecture in High-Grade Serous Ovarian Cancer.#172074NCBI PubMed Central